Zing Open Zing
Technology

IBM's Anderon Finalizes $1 Billion Government Award for Quantum Chip Foundry

17 September 2026 · Source balance: Centre

IBM's quantum subsidiary, Anderon, has finalized a one billion dollar award from the U.S. Department of Commerce under the CHIPS and Science Act. Announced in May and completed in September 2026, the agreement matches IBM's own one billion dollar investment, bringing total capitalization to two billion dollars. Anderon operates a 300-millimeter quantum wafer foundry in Albany, New York, and serves multiple quantum hardware vendors across the industry, not just IBM. The facility manufactures specialized quantum wafers for superconducting quantum processors. This represents the largest single federal quantum R&D investment to date and aims to strengthen U.S. leadership in quantum computing, support national supply chains, and accelerate the commercialization of fault-tolerant quantum systems targeted for 2029. The foundry is already producing quantum wafers.

Key facts

  • Anderon finalized a $1 billion CHIPS and Science Act award on September 16, 2026
  • IBM committed a matching $1 billion investment, totaling $2 billion in capitalization
  • The facility operates a 300-millimeter quantum wafer foundry in Albany, New York
  • Anderon serves multiple quantum hardware vendors, not solely IBM's internal needs
  • IBM's $1 billion award accounts for roughly half of the entire Department of Commerce quantum package
  • Production of quantum wafers already underway at the facility
  • Initiative targets delivery of commercial fault-tolerant quantum computers by 2029
  • Broader $2.013 billion federal quantum investment split across nine companies

How different outlets framed it

Right-leaning coverage: Trump administration leadership in driving U.S. quantum innovation through federal support. One source notes the administration's heavy involvement in quantum strategy mirrors intervention in semiconductors and critical minerals.

Limits of this briefing

Coverage is uniformly positive and technical; analysis of competitive concerns about IBM's dual role as both majority customer and operator is limited. No critical perspective from quantum industry competitors was located.

Sources

More stories

See all latest stories